On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

Referred to by medics as benign prostate enlargement (BPE), the condition is not a cancer and those with it are not at a higher ... Medicine to reduce the size of the prostate and relax a patient’s ...

This Movember, prioritize your health by getting screened for prostate cancer. Early detection saves lives—learn why regular ...

Prostate cancer can be classified as the second most common and lethal cancer among men on the planet after skin cancer.

When the company I worked for invited me to a routine executive health check, I was a regular park runner and not a smoker.

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

The month of November each year is dedicated to raising awareness of health issues affecting men, such as mental health and ...

Doctors removed his prostate, but his cancer returned a year later ... (Gary made a shape with his hands to show how the big ...

Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

During Movember, Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, ...